Journal Article (Letter)

DKFZ-2025-01737

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Efficacy of idecabtagene vicleucel in patients with relapsed/refractory multiple myeloma and prior central nervous system manifestation: A multicenter real-world analysis.

Maulhardt, M. ; Call, S. ; Boyadzhiev, H. ; Albici, A. M. ; Hörster, K.DKFZ* ; Boquoi, A.DKFZ* ; Janjetovic, S. ; Ossami Saidy, A. ; Teichert, M.DKFZ* ; Brioli, A. ; Schultze-Florey, C. ; Heidel, F. ; Schindler, P. ; Schub, N. ; Aydilek, E. ; Stelljes, M. ; Daskalakis, M. ; Krekeler, C. ; Hasenkamp, J. ; Khandanpour, C. ; Bacher, U. ; Reinhardt, H. C.DKFZ* ; Lenz, G. ; Stölzel, F. ; Pabst, T. ; von Tresckow, B.DKFZ* ; Wulf, G. ; Berning, P. ; Shumilov, E.

2025
John Wiley & Sons Ltd. Hoboken

---

Contributing Institute(s):

1. DKTK Koordinierungsstelle Essen/Düsseldorf (ED01)

Research Program(s):

1. 899 - ohne Topic (POF4-899) (POF4-899)

Appears in the scientific report 2025

---

Database coverage:
; ; Article Processing Charges ; Clarivate Analytics Master Journal List ; Current Contents - Clinical Medicine ; DEAL Wiley ; DOAJ Seal ; Essential Science Indicators ; Fees ; IF >= 5 ; JCR ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection

---